28 Followers SGX:8YY - Biolidics (SGD 0.315) BIOLIDICS LIMITED
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   
Add Alert 


Yahoo Finance

SGD 0.315    +0.010 (+3.28%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

23 Sep 2020


Overview

23 Sep 2020

52 Wk Range: 0.175 - 0.885

Day's Range: 0.295 - 0.325

Last Volume: 3,284,500

Current Yield: 0%

Projected Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

23 Sep 2020

Metric 8YY S.Median
Beta 0.48 0.14
VaR 57.97 50.5
E.Shortfall 109.07 94.2
Liquidity 2.67M 1.05M

Fundamental

23 Sep 2020

PE: NA

Market Cap: 83.2M

Price Over Book: 7.607

Price Over Sales: 10.52

Return On Assets: -20.2%

Return On Equity: -29.3%

Shares By Insiders: 66.3%

General

CEO: Man Chun Leong

Founded Year: 2009

Headquarters: Singapore

Shares Outstanding: 260.4M

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Biolidics Ltd. operates as a medical technology company. It focuses on the development of cell enrichment systems which, when combined with other analytical tests, have applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The firm has developed and commercialised a fully automated IVD medical device ClearCell FX1, which allows users of the system to perform liquid biopsies to test for the presence of cancer cells. It operates through the following segments: Technical and Product Development, Global Commercial Channel Management, and Corporate. The Technical and Product Development segment involves identifying and assessing collaboration partners and their technology, provision of technical expertise in revenue generating collaboration projects, and product innovation and improvement. The Global Commercial Channel Management segment deals with the management of global distributorship network and direct customers. The Corporate segment refers to the corporate functions in supporting the operations of the group. The company was founded by Johnson Chen on July 19, 2009 and is headquartered in Singapore.